Konig H, Härtel N, Schultheis B, Schatz M, Lorentz C, Melo JV, Hehlmann R, Hochhaus A, La Rosée P. Enhanced Bcr-Abl-specific antileukemic activity of arsenic trioxide through glutathione-depletion in imatinib-resistant cells. Haematologica [Internet]. 2007Jun.1 [cited 2026Nov.15];92(6):838-41. Available from: https://haematologica.org/article/view/4479